Menu Close

Another angle on Alzheimer’s: CSF, proteomics, and metabolic enzymes

Currently there are no objective, easily assessed diagnostic markers for Alzheimer’s disease, and no good therapeutic options. Taking an agnostic approach, proteomics expert Hanno Steen, Ph.D., and neurobiologist Judith Steen, Ph.D., who share a lab at Boston Children’s Hospital, teamed up to analyze proteomics data from the cerebrospinal fluid (CSF) that bathes the brain, combining data from 10 different study cohorts, most of which had been published before.